Filing Details
- Accession Number:
- 0000950117-10-000225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-16 12:00:00
- Reporting Period:
- 2010-02-12
- Filing Date:
- 2010-02-16
- Accepted Time:
- 2010-02-16 17:32:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 50710 | Javelin Pharmaceuticals Inc | JAV | Pharmaceutical Preparations (2834) | 880471759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188560 | Neil Flanzraich | C/O Javelin Pharmaceuticals, Inc. 125 Cambridgepark Drive Cambridge MA 02140 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 | Acquisiton | 2010-02-12 | 24,000 | $1.26 | 638,937 | No | 4 | M | Direct | |
| Common Stock, Par Value $.001 | Acquisiton | 2010-02-12 | 115,483 | $1.25 | 754,420 | No | 4 | P | Direct | |
| Common Stock, Par Value $.001 | Acquisiton | 2010-02-16 | 50,000 | $1.36 | 804,420 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2010-02-12 | 24,000 | $0.00 | 24,000 | $1.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-12-31 | 2019-05-01 | No | 4 | M | Direct |
Footnotes
- The 115,483 shares of common stock were purchased in multiple same-way open market transactions at different prices ranging from $1.24 to $1.28. The weighted average purchase price for the shares was $1.2488. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- The 50,000 shares of common stock were purchased in multiple same-way open market transactions at different prices ranging from $1.33 to $1.36. The weighted average purchase price for the shares was $1.3566. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
- Granted under the Issuer's 2005 Omnibus Stock Incentive Plan.
Billionaire Hedge Funds
